---
document_datetime: 2023-09-21 18:59:19
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tegsedi-epar-all-authorised-presentations_en.pdf
document_name: tegsedi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.813058
conversion_datetime: 2025-12-20 14:23:46.249057
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EMA Number       | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size             |
|------------------|-------------------|------------|------------------------|---------------------------|----------------------------|---------------------------|-----------------------|
| EU/1/18/1296/001 | Tegsedi           | 284 mg     | Solution for injection | Subcutaneous use          | Pre-filled syringe (glass) | 1.5 ml (189 mg/ml)        | 1 pre-filled syringe  |
| EU/1/18/1296/002 | Tegsedi           | 284 mg     | Solution for injection | Subcutaneous use          | Pre-filled syringe (glass) | 1.5 ml (189 mg/ml)        | 4 pre-filled syringes |